Cargando…
Current State of Human Gene Therapy: Approved Products and Vectors
In the realm of gene therapy, a pivotal moment arrived with Paul Berg’s groundbreaking identification of the first recombinant DNA in 1972. This achievement set the stage for future breakthroughs. Conditions once considered undefeatable, like melanoma, pancreatic cancer, and a host of other ailments...
Autores principales: | Shchaslyvyi, Aladdin Y., Antonenko, Svitlana V., Tesliuk, Maksym G., Telegeev, Gennadiy D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609992/ https://www.ncbi.nlm.nih.gov/pubmed/37895887 http://dx.doi.org/10.3390/ph16101416 |
Ejemplares similares
-
Advanced Therapy Medicinal Products in Vitiligo; Current Status,
Future Prospect, and Approved Treatments
por: Ghashghaei, Shahriar, et al.
Publicado: (2023) -
Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders
por: Shahryari, Alireza, et al.
Publicado: (2019) -
Current landscape of clinical development and approval of advanced therapies
por: Iglesias-Lopez, Carolina, et al.
Publicado: (2021) -
China approves first gene therapy
por: Pearson, Sue, et al.
Publicado: (2004) -
Current FDA-Approved Therapies for High-Grade Malignant Gliomas
por: Fisher, Jacob P., et al.
Publicado: (2021)